Achieve instantly radiant skin with light therapy.
See how our products are changing lives based on verified customer feedback
Achieve instantly radiant skin with light therapy.
Hydrate and lift for a youthful glow.
Pairs perfectly with your favorite face oil.
Transform your skincare routine with confidence.
Results based on 700+ reviews submitted by verified customers.
Real People. Real Results
Shannon & Ray
"My skin has never looked this good! 😍 The EMS and red light therapy have helped clear my acne and even out my complexion. My skin feels tighter, plumper, and so much healthier!"
"This has completely transformed my skincare routine! My acne scars are fading, my pores look smaller, and my skin just feels fresher and more youthful!"
Shan & Ray uses: Velinee - Radiance Red Light Lifter
Rachael & Laura
"I was skeptical at first, but WOW! After just a few weeks, my fine lines are fading, and my face looks more lifted. It’s like a mini facelift at home!"
"I’ve struggled with dull skin for years, but after using this EMS massager, my skin is glowing! It absorbs my serums better, and my face feels tighter and smoother!"
Rachael & Laura. uses: Velinee - Radiance Red Light Lifter
Sally & Claire
"I use this every night with my favorite serum, and my skin has never been so plump and radiant. My fine lines are softening, and I love how it helps my products absorb better!"
"This little device is magic! ✨ It helps with puffiness in the morning and makes my skin feel so firm. My jawline looks more defined, and my breakouts have reduced drastically!"
Sally & Claire uses: Velinee - Radiance Red Light Lifter
91%
Users noticed firmer, more radiant skin and a visible reduction in wrinkles with the EMS Red Light Massager. Results from a double-blind, in-vivo clinical trial involving 40 subjects, aged 21-62, over 150 days.
86%
agree they will still be using Velinee in three years.
91%
Users noticed firmer, more radiant skin and a visible reduction in wrinkles with the EMS Red Light Massager. Results from a double-blind, in-vivo clinical trial involving 40 subjects, aged 21-62, over 150 days.